A historic shift in Canadian drug policy has happened, as the authorities allow the availability of psilocybin mushrooms for therapeutic purposes. Until now, these substances were heavily restricted, but a mounting body of evidence suggests they may offer aid for psychological illnesses like anxiety. The new policy represents a major step toward re